Home LiteratureArticle Details
PMID: 21710622 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Intramural

Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions.

Annals of neurology ·Vol. 70 ·No. 1 ·2011-07-00 ·Pages 22-9

Gaitán MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, Massacesi L, Reich DS

Abstract

Multiple sclerosis (MS) lesions develop around small, inflamed veins. New lesions enhance with gadolinium on magnetic resonance imaging (MRI), reflecting disruption of the blood-brain barrier (BBB). Single time point results from pathology and standard MRI cannot capture the spatiotemporal expansion of lesions. We investigated the development and expansion of new MS lesions, focusing on the dynamics of BBB permeability. We performed dynamic contrast-enhanced (DCE) MRI in relapsing-remitting MS. We obtained data over 65 minutes, during and after gadolinium injection. We labeled spatiotemporal enhancement dynamics as centrifugal when initially central enhancement expanded outward and centripetal when initially peripheral enhancement gradually filled the center. We detected 34 enhancing lesions in 200 DCE-MRI scans. In 65%, enhancement first appeared as a closed ring; in 18%, as a nodule; and in 18%, as an open ring. Lesions with initially nodular enhancement were smaller than those initially enhancing as rings (p < 0.0001). All initially nodular lesions enhanced centrifugally, whereas initially ringlike lesions enhanced centripetally, becoming nodular if small (82%) or nearly nodular if larger (18%). Open-ring lesions were periventricular or juxtacortical and enhanced centripetally. Centrifugally enhancing lesions evolved into centripetally enhancing lesions over several days. The rapid change of enhancement dynamics from centrifugal to centripetal reflects the outward growth of MS lesions around their central vein and suggests that factors mediating lesion growth and tissue repair derive from different locations at different times. We propose a model of new lesion growth that unites our imaging observations with existing pathology data.

MeSH Terms
Adult Blood-Brain Barrier/metabolism,pathology Capillary Permeability/physiology Female Humans Magnetic Resonance Imaging/methods,trends Male Middle Aged Multiple Sclerosis, Relapsing-Remitting/metabolism,pathology Young Adult
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Gaitán María I
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Shea Colin D
Evangelou Iordanis E
Stone Roger D
Fenton Kaylan M
Bielekova Bibiana
Massacesi Luca
Reich Daniel S
References (36)
36 references, click to expand
  1. The onset and progression of the lesion in multiple sclerosis.
    J Neurol Sci. 1975 Jun;25(2):165-82 PMID: 1151432
  2. The blood-brain barrier, chemokines and multiple sclerosis.
    Biochim Biophys Acta. 2011 Feb;1812(2):220-30 PMID: 20692338
  3. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.
    Ann Neurol. 2004 Apr;55(4):458-68 PMID: 15048884
  4. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis.
    Acad Radiol. 2008 Jan;15(1):15-23 PMID: 18078903
  5. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study.
    Brain. 2004 Jan;127(Pt 1):111-9 PMID: 14570816
  6. Open-ring imaging sign: highly specific for atypical brain demyelination.
    Neurology. 2000 Apr 11;54(7):1427-33 PMID: 10751251
  7. Enhanced magnetic resonance imaging in multiple sclerosis.
    Mult Scler. 2000 Oct;6(5):320-6 PMID: 11064441
  8. Protective effects of microglia in multiple sclerosis.
    Exp Neurol. 2010 Sep;225(1):24-8 PMID: 19409897
  9. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.
    Magn Reson Med. 1991 Feb;17(2):357-67 PMID: 2062210
  10. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study.
    Brain. 2000 Aug;123 ( Pt 8):1667-76 PMID: 10908196
  11. The blood-brain barrier in cortical multiple sclerosis lesions.
    J Neuropathol Exp Neurol. 2007 Apr;66(4):321-8 PMID: 17413323
  12. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage.
    Brain. 2007 Aug;130(Pt 8):2186-98 PMID: 17617655
  13. Disruption of central nervous system barriers in multiple sclerosis.
    Biochim Biophys Acta. 2011 Feb;1812(2):252-64 PMID: 20619340
  14. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
    Neuroimaging Clin N Am. 2008 Nov;18(4):563-76, ix PMID: 19068402
  15. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
    Radiology. 1988 Oct;169(1):117-22 PMID: 3420246
  16. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.
    Ann Neurol. 2001 Sep;50(3):389-400 PMID: 11558796
  17. MRI to monitor treatment efficacy in multiple sclerosis.
    J Neuroimaging. 2007 Apr;17 Suppl 1:50S-55S PMID: 17425736
  18. Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse.
    Mult Scler. 2003 Mar;9(2):189-98 PMID: 12708814
  19. A new scale for evaluating disability in multiple sclerosis.
    Neurology. 1955 Aug;5(8):580-3 PMID: 13244774
  20. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis.
    Ann Neurol. 1998 Jun;43(6):809-14 PMID: 9629851
  21. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.
    Eur J Radiol. 2009 Jun;70(3):465-74 PMID: 18359598
  22. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
    Neurology. 1990 Feb;40(2):229-35 PMID: 2300240
  23. Magnetic resonance perfusion and permeability imaging in brain tumors.
    Neuroimaging Clin N Am. 2009 Nov;19(4):527-57 PMID: 19959004
  24. MR imaging in multiple sclerosis: review and recommendations for current practice.
    AJNR Am J Neuroradiol. 2010 Jun;31(6):983-9 PMID: 20019103
  25. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Neuropathol Appl Neurobiol. 2009 Apr;35(2):132-46 PMID: 19077110
  26. Enhancing patterns in multiple sclerosis: evolution and persistence.
    AJNR Am J Neuroradiol. 2001 Apr;22(4):664-9 PMID: 11290475
  27. MRI as an outcome in multiple sclerosis clinical trials.
    Neurology. 2009 Feb 24;72(8):705-11 PMID: 19073945
  28. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.
    Ann Neurol. 1997 Nov;42(5):783-93 PMID: 9392578
  29. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Ann Neurol. 2009 Dec;66(6):739-53 PMID: 20035511
  30. MR venography of multiple sclerosis.
    AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1039-42 PMID: 10871010
  31. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis.
    J Neuropathol Exp Neurol. 2006 Sep;65(9):855-65 PMID: 16957579
  32. Ring-enchancement in multiple sclerosis: marker of disease severity.
    Mult Scler. 2001 Jun;7(3):167-71 PMID: 11475440
  33. Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis.
    Arch Neurol. 1992 Jul;49(7):687-9 PMID: 1497493
  34. Ring and nodular multiple sclerosis lesions: a retrospective natural history study.
    Neurology. 2010 Mar 9;74(10):851-6 PMID: 20211910
  35. The pathological evolution of multiple sclerosis.
    Neuropathol Appl Neurobiol. 1992 Aug;18(4):319-34 PMID: 1528388
  36. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.
    Magn Reson Med. 1990 Oct;16(1):117-31 PMID: 2255233
Article Info
Journal
Annals of neurology
Abbr.
Ann Neurol
ISSN
1531-8249
Published
2011-07-00
Epub
2011-00-27
Pages
22-9
Language
English
Region
United States
NLM ID
7707449
PMCID
PMC3143223
Subset
IM
Grants
Intramural NIH HHS · Z99 NS999999 · United States
Intramural NIH HHS · ZIA NS003055-03 · United States
Intramural NIH HHS · ZIA NS003119-01 · United States
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com